Showing results (1411-1420 of 2,232) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatmentTsai-Yueh Luo, Ying-Hsia Shih, Chiung-Yu Chen, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
(99m)Tc-tricarbonyl complexes functionalized with anthracenyl fragments: synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cellsRute F Vitor, Teresa Esteves, Fernanda Marques, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticlesYi Wang, Xinrong Liu, Kayoko Nakamura, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinomaRoberto Manfredi, Nicola Dentale, Benedetta Piergentili, et al.Cancer Biotherapy & Radiopharmaceuticals|November 3, 2009
The use of [(125)I] scintigraphic in vivo imaging in melanoma-bearing mice for a rapid prescreening of vectors to melanoma tissueElisabeth Miot-Noirault, Janine Papon, Marilyne Gardette, et al.Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Practical dosimetry of 131I in patients with thyroid carcinomaJames C SissonCancer Biotherapy & Radiopharmaceuticals|March 28, 2002
The experimental research of R-phycoerythrin subunits on cancer treatment: a new photosensitizer in PDTBei Huang, Guang-Ce Wang, Chen-Kui Zeng, et al.Cancer Biotherapy & Radiopharmaceuticals|March 28, 2002
Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor responseRuby MeredithCancer Biotherapy & Radiopharmaceuticals|September 17, 2014
Regulation of biokinetics of (65)Zn by curcumin and zinc in experimentally induced colon carcinogenesis in ratsKinnri Jain, Devinder K DhawanCancer Biotherapy & Radiopharmaceuticals|January 15, 2015
Shelf-life of ɛ-lysyl-3-(trimethylstannyl)benzamide immunoconjugates, precursors for 211At labeling of antibodiesEmma Aneheim, Jenny Halleröd, Per Albertsson, et al.Pageof 224